Ignite Creation Date:
2025-12-24 @ 2:46 PM
Ignite Modification Date:
2025-12-26 @ 1:45 PM
Study NCT ID:
NCT01899859
Status:
COMPLETED
Last Update Posted:
2015-02-23
First Post:
2013-07-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis
Sponsor:
Galectin Therapeutics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-07
Start Date Type:
None
Primary Completion Date:
2015-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-02
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-09
First Submit QC Date:
None
Study First Post Date:
2013-07-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-02-19
Last Update Post Date:
2015-02-23
Last Update Post Date Type:
ESTIMATED